By Stephen Nakrosis 
 

Elanco Animal Health Inc. (ELAN) said it received a second request for information from the U.S. Federal Trade Commission regarding its planned acquisition of Bayer AG's animal health business.

In August, the two companies announced a deal that will see Elanco acquire the unit in a cash-and-stock deal valued at $7.6 billion. At the time, the companies said the transaction was expected to close by the middle of next year.

Elanco said Monday, "The request was anticipated as part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the review continues to progress as expected."

 

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

December 09, 2019 18:30 ET (23:30 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bayer Charts.
Bayer (TG:BAYN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bayer Charts.